Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Observation × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9 Prostatic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Endometrial Neoplasms 7 Lung Neoplasms 6 Breast Neoplasms 6 Colorectal Neoplasms 5 Oropharyngeal Neoplasms 4 Stomach Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Leukemia, Myeloid, Acute 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Pathologic Complete Response 2 Meningioma 2 Melanoma 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia 2 Leiomyoma 2 Esophageal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Brain Neoplasms 2 Bone Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1

Interventions

Blood Specimen Collection 4 Specimen Handling 3 COVID-19 Vaccines 3 Surveys and Questionnaires 2 Standard of Care 2 Practice Guidelines as Topic 2 COH04S1 COVID-19 vaccine 2 tocilizumab 1 sotrovimab 1 ciclesonide 1 Therapeutics 1 Telemedicine 1 Observation 1 Nutritional Status 1 Niclosamide 1 NVX-CoV2373 adjuvated lipid nanoparticle 1 Influenza Vaccines 1 IMM-101 1 HuMax-IL8 1 Exercise 1 Diagnostic Tests, Routine 1 Data Collection 1 CVnCoV COVID-19 vaccine 1 2019-nCoV Vaccine mRNA-1273 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡